Patients are at risk of respiratory depression and acute hypercapnia during sedation and recovery from anesthesia. Desaturation on pulse oximetry is a late sign and can be significantly masked by administration of supplemental O 2 .
To the Editor,
Patients are at risk of respiratory depression and acute hypercapnia during sedation and recovery from anesthesia. Desaturation on pulse oximetry is a late sign and can be significantly masked by administration of supplemental O 2 . 1 Global standards vary on the use of end-tidal or expired CO 2 measurement during sedation; 2,3 however, traditional CO 2 measurement can be technically challenging depending on the airway management technique and the procedure itself in the case of the shared airway. Transcutaneous CO 2 partial pressure (tcpCO 2 ) is a non-invasive surrogate measure that correlates well with PaCO 2 on arterial blood gas analysis. 4 ,A Transcutaneous CO 2 partial pressure offers a more accurate measure of CO 2 compared with capnography with nasal prongs because of the open circuit arrangement of the latter. We aimed to evaluate the change in tcpCO 2 during sedation for gastrointestinal endoscopy.
Following ethics approval (HREC LNR/17/PMCC/97), we conducted a prospective observational cohort study using tcpCO 2 A total of 56 patients were investigated. Procedures included colonoscopy (n = 31; 55%), combined colonoscopy and gastroscopy (n = 13; 23%), gastroscopy (n = 7; 13%), and flexible sigmoidoscopy (n = 5; 9%). All patients received propofol; the majority received adjunct opioid (fentanyl or alfentanil; n = 42; 75%) and three patients also received midazolam. The mean duration of sedation was 27.6 (standard deviation 10.3) min.
We confirmed that tcpCO 2 is a successful method of non-invasively monitoring the response to dynamic respiratory changes associated with sedation. Nevertheless, only one of the six patients with hypoxia presented with hypercapnia, supporting findings that hypoxia is a separate phenomenon and so tcpCO 2 is unlikely to be a reliable monitor for rapid detection of intra-procedure hypoxia and adverse respiratory events. tcpCO 2 in patients who had received opioids. Future areas for investigation include the application of tcpCO 2 monitoring in the postanesthesia care unit and in specific target populations, e.g., those with PCAs, intrathecal morphine, or in cases such as robotic or laparoscopic surgery, where systemic absorption of CO 2 may continue postoperatively. 5 Overall, we believe that tcpCO 2 monitoring has the potential to be a useful tool in addition to expired CO 2 monitoring or in situations where traditional monitoring cannot be readily utilized. 
